Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis

被引：78
|
作者：
Greco, A
Minghetti, L
Sette, G
Fieschi, C
Levi, G
机构：
[1] Ist Super Sanita, Lab Pathophysiol, I-00161 Rome, Italy
[2] Univ Rome La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy
来源：
NEUROLOGY | 1999年 / 53卷 / 08期
关键词：
8-epi-prostaglandin F-2 alpha; prostaglandin E-2; CSF; MS; human; lipid peroxidation; oxidative stress;
D O I：
10.1212/WNL.53.8.1876
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The CSF level of the isoprostane 8-epi-prostaglandin (PG)-F-2 alpha (a reliable marker of oxidative stress in vivo) was three times higher in subjects with definite MS than in a benchmark group of subjects with other neurologic diseases. This increase was not correlated with that of PGE, levels, measured as an index of cyclooxygenase activity, and was much lower in steroid-treated patients. The levels of 8-epi-PGF(2 alpha) were moderately correlated with the degree of disability.
引用
收藏
页码：1876 / 1879
页数：4
相关论文
共 50 条
  • [31] Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis
    Matejcikova, Z.
    Mares, J.
    Prikrylova-Vranova, H.
    Klosova, J.
    Sladkova, V.
    Zapletalova, J.
    Hlustik, P.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2014, 261 : S333 - S333
  • [32] Cerebrospinal fluid nitrate levels in patients with multiple sclerosis
    de Bustos, F
    Navarro, JA
    de Andrés, C
    Molina, JA
    Jiménez-Jiménez, FJ
    Ortí-Pareja, M
    Gasalla, T
    Tallón-Barranco, A
    Martínez-Salio, A
    Arenas, J
    EUROPEAN NEUROLOGY, 1999, 41 (01) : 44 - 47
  • [33] Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis
    Ehling R.
    Pauli F.D.
    Lackner P.
    Kuenz B.
    Santner W.
    Lutterotti A.
    Gneiss C.
    Hegen H.
    Schocke M.
    Deisenhammer F.
    Berger T.
    Reindl M.
    Fluids and Barriers of the CNS, 8 (1)
  • [34] Cerebrospinal fluid proteome profiles of patients with multiple sclerosis
    Komori, M.
    Matsuyama, Y.
    Nirasawa, T.
    Thiele, H.
    Saida, T.
    Tanaka, M.
    Tomimoto, H.
    Takahashi, R.
    Tashiro, K.
    Ikegawa, M.
    Kondo, T.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S64 - S65
  • [35] Cerebrospinal fluid proteome profile in patients with multiple sclerosis
    Tumani, H.
    Suessmuth, S.
    Tauscher, G.
    Brettschneider, J.
    Felk, S.
    Gillardon, F.
    Lehmensiek, V.
    MULTIPLE SCLEROSIS, 2006, 12 : S15 - S16
  • [36] Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis
    Unger, Marcus M.
    Oertel, Wolfgang H.
    Tackenberg, Bjorn
    NEUROENDOCRINOLOGY LETTERS, 2013, 34 (01) : 14 - 17
  • [37] Proteome analysis of cerebrospinal fluid in patients with multiple sclerosis
    Timani, H.
    Suessmuth, S.
    Brettschneider, J.
    Palm, C.
    Guttman, I.
    Lehmensiek, V.
    MULTIPLE SCLEROSIS, 2007, 13 : S153 - S153
  • [38] Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis
    Matejcikova, Z.
    Mares, J.
    Prikrylova-Vranova, H.
    Klosova, J.
    Sladkova, V.
    Zapletalova, J.
    Hlustik, P.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 505 - 505
  • [39] Cytokine activation in cerebrospinal fluid of patients with multiple sclerosis
    Martynova, E.
    Khabirov, F.
    Khaybullin, T.
    Rizvanov, A.
    Khaiboullina, S.
    Akhmedova, G.
    Granatov, E.
    Shakirzanova, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 446 - 446
  • [40] Nitrotyrosine, neuronal and inducible nitric oxide synthetase in serum and cerebrospinal fluid of patients with multiple sclerosis: potential markers of oxidative stress
    Andreadou, E.
    Kemanetzoglou, E.
    Constantinides, V.
    Zoga, M.
    Boufidou, F.
    Nikolaou, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 583 - 584
12345